- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Publication
Article
Dermatology Times
Dermatology Times, October 2018 (Vol. 39, No. 10)Volume39 Issue 10
Skin differences in men and women
Author(s):
Gender and sex play a part in detemining which topical products are most successful for patients. This table is compiled based on a review of articles form the International Journal of Women's Dermatology.
Click to view the table
In this table, we highlight the biophysical, chemcial and physiological skin differences between men and women. These are differences that may determine which topical products are better suited for patient by gender. The following summary was compiled based on a review of articles that compared skin differences by sex. The review was published in the International Journal of Women's Dermatology this year.
(Click here for a
printable PDF)
Articles in this issue
Skin differences in men and women
Education at mammogram impacts skin cancer awareness
Patients want genetic testing
The state of off-label drug laws
Combined atopic dermatitis treatment shows promise
Optimizing fillers for men
The value of online patient reviews
AIVITA Biomedical names new CFO, VP of business development
Epiphany Dermatology partners with Sun City Dermatology
The burden of electronic health record implementation
What are cosmeceutical peptides?
A critical first step in defining great problems
José Raúl Montes, M.D., sings a metaphor for injectable synergy
FDA approves tretinoin lotion acne treatment
NYC, Philadelphia dermatology firms merge
Related Videos
Balancing Effective AD Symptom Control with Long-Term Safety in New Therapies
Key Considerations for Evaluating Ruxolitinib Cream as a Treatment for Young Children
Supporting Caregivers in Successful Long-Term Atopic Dermatitis Management: The Role of Dermatologists
Challenges and Emerging Solutions in Treatment for Age Groups: Addressing Disease Control, Safety, and Usability
Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis
Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma
Differentiating Between JAK Inhibitors in Clinical Practice
IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
Clinical Attributes of IL-17 Inhibitors in Psoriasis
Laboratory Monitoring with Oral JAK Inhibitors
Related Content
